Anthocyanins in chronic diseases: the power of purple

Anthocyanins are mainly purple-coloured phenolic compounds of plant origin that as secondary metabolites are important in plant survival. Understanding their health benefits in humans requires sourcing these unstable compounds in sufficient quantities at a reasonable cost, which has led to improved...

Full description

Saved in:
Bibliographic Details
Main Authors: Sunil K. Panchal, Oliver Dean John, Michael L. Mathai, Lindsay Brown
Format: Article
Language:English
Published: MDPI 2022
Subjects:
Online Access:https://eprints.ums.edu.my/id/eprint/42376/1/FULL%20TEXT.pdf
https://eprints.ums.edu.my/id/eprint/42376/
https://doi.org/10.3390/nu14102161
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.ums.eprints.42376
record_format eprints
spelling my.ums.eprints.423762024-12-23T03:21:39Z https://eprints.ums.edu.my/id/eprint/42376/ Anthocyanins in chronic diseases: the power of purple Sunil K. Panchal Oliver Dean John Michael L. Mathai Lindsay Brown QK710-899 Plant physiology SB354-402 Fruit and fruit culture Anthocyanins are mainly purple-coloured phenolic compounds of plant origin that as secondary metabolites are important in plant survival. Understanding their health benefits in humans requires sourcing these unstable compounds in sufficient quantities at a reasonable cost, which has led to improved methods of extraction. Dark-coloured fruits, cereals and vegetables are current sources of these compounds. The range of potential sustainable sources is much larger and includes non-commercialised native plants from around the world and agri-waste containing anthocyanins. In the last 5 years, there have been significant advances in developing the therapeutic potential of anthocyanins in chronic human diseases. Anthocyanins exert their beneficial effects through improvements in gut microbiota, oxidative stress and inflammation, and modulation of neuropeptides such as insulin-like growth factor-1. Their health benefits in humans include reduced cognitive decline; protection of organs such as the liver, as well as the cardiovascular system, gastrointestinal tract and kidneys; improvements in bone health and obesity; and regulation of glucose and lipid metabolism. This review summarises some of the sources of anthocyanins and their mechanisms and benefits in the treatment of chronic human diseases. MDPI 2022 Article NonPeerReviewed text en https://eprints.ums.edu.my/id/eprint/42376/1/FULL%20TEXT.pdf Sunil K. Panchal and Oliver Dean John and Michael L. Mathai and Lindsay Brown (2022) Anthocyanins in chronic diseases: the power of purple. Nutrients, 14. pp. 1-30. https://doi.org/10.3390/nu14102161
institution Universiti Malaysia Sabah
building UMS Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaysia Sabah
content_source UMS Institutional Repository
url_provider http://eprints.ums.edu.my/
language English
topic QK710-899 Plant physiology
SB354-402 Fruit and fruit culture
spellingShingle QK710-899 Plant physiology
SB354-402 Fruit and fruit culture
Sunil K. Panchal
Oliver Dean John
Michael L. Mathai
Lindsay Brown
Anthocyanins in chronic diseases: the power of purple
description Anthocyanins are mainly purple-coloured phenolic compounds of plant origin that as secondary metabolites are important in plant survival. Understanding their health benefits in humans requires sourcing these unstable compounds in sufficient quantities at a reasonable cost, which has led to improved methods of extraction. Dark-coloured fruits, cereals and vegetables are current sources of these compounds. The range of potential sustainable sources is much larger and includes non-commercialised native plants from around the world and agri-waste containing anthocyanins. In the last 5 years, there have been significant advances in developing the therapeutic potential of anthocyanins in chronic human diseases. Anthocyanins exert their beneficial effects through improvements in gut microbiota, oxidative stress and inflammation, and modulation of neuropeptides such as insulin-like growth factor-1. Their health benefits in humans include reduced cognitive decline; protection of organs such as the liver, as well as the cardiovascular system, gastrointestinal tract and kidneys; improvements in bone health and obesity; and regulation of glucose and lipid metabolism. This review summarises some of the sources of anthocyanins and their mechanisms and benefits in the treatment of chronic human diseases.
format Article
author Sunil K. Panchal
Oliver Dean John
Michael L. Mathai
Lindsay Brown
author_facet Sunil K. Panchal
Oliver Dean John
Michael L. Mathai
Lindsay Brown
author_sort Sunil K. Panchal
title Anthocyanins in chronic diseases: the power of purple
title_short Anthocyanins in chronic diseases: the power of purple
title_full Anthocyanins in chronic diseases: the power of purple
title_fullStr Anthocyanins in chronic diseases: the power of purple
title_full_unstemmed Anthocyanins in chronic diseases: the power of purple
title_sort anthocyanins in chronic diseases: the power of purple
publisher MDPI
publishDate 2022
url https://eprints.ums.edu.my/id/eprint/42376/1/FULL%20TEXT.pdf
https://eprints.ums.edu.my/id/eprint/42376/
https://doi.org/10.3390/nu14102161
_version_ 1819911291601420288
score 13.223943